Study on dose requirement of dexmedetomidine with the use of Bispectral Index Monitoring
Phase 2
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2024/03/064505
- Lead Sponsor
- Amrita Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
American Society of Anesthesiologists physical status (ASA PS) 2 to 3,
-Patients undergoing total parotidectomy with nerve conduction studies
Exclusion Criteria
-Patients with basal HR less than sixty per min,
-beta blockers,
-heart blocks,
-hypersensitivity to dexmedetomidine
-nasal intubation or fibreoptic intubation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the intraoperative dexmedetomidine infusion dose requirement with and without bispectral index (BIS) monitoring in patients undergoing total parotidectomy under general anesthesia without use of muscle relaxants.Timepoint: End of surgery
- Secondary Outcome Measures
Name Time Method To compare intraoperative patient immobility, hemodynamic responses, sevoflurane & propofol consumption, need for intervention if patient moves, incidence of hypotension, use of vasopressors & time taken for extubation in both groups.Timepoint: patient immobility will be assessed at end of surgery, hemodynamic responses will be assessed every half hourly during surgery, sevoflurane & propofol consumption will be noted at the end of surgery, & the time taken for extubation will be documented at the end of surgery.